Evidence map›Paper›PMID 31312380›Full record

ArticleAmerican journal of translational research2019

Molecular simulation studies on B-cell lymphoma/leukaemia 11A (BCL11A).

Sayed Abdulazeez

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Pleiotropic Effects of Polymorphisms in theInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Frontiers in pharmacology · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Bacterial Quorum-Sensing Molecules as Promising Natural Inhibitors ofFrontiers in cellular and infection microbiology · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Sayed AbdulazeezDepartment of Genetic Research, Institute for Research and Medical Consultation (IRMC), Imam Abdulrahman Bin Faisal University Dammam, Saudi Arabia.
Imam Abdulrahman Bin Faisal University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B-cell lymphoma/leukaemia 11A (BCL11A) is a modulator of foetal-to-adult globin switching and is involved in brain development and normal lymphopoiesis. The three-dimensional structure of BCL11A and its structural domains had not yet been completely determined; hence, this study aimed to elucidate the structural domains of BCL11A. Molecular modelling and dynamics simulation studies were conducted using in silico tools with the templates selected based on Basic Local Alignment Search Tool (BLAST) searches of the Protein Data Bank (PDB). Ten protein models were generated using the MODELLER software, and the best model was selected according to the Discrete Optimised Protein Energy (DOPE) score and validated using the RAMPAGE server by evaluation of the Ramachandran plot. More than 93% of the amino acid residues of the best model of BCL11A were found to be in the favoured and allowed regions. The best model was validated using a 100-ns time span molecular dynamics simulation. The root-mean-square deviation, root-mean-square fluctuation, and radius of gyration values were found to explain the stability of the best BCL11A protein molecular model generated in the study. The validated best model of the BCL11A protein may be useful for effective modulator studies on foetal-to-adult globin switching and related research.

Indexed as

BCL11Ahomology modellingmolecular dynamics simulationPhyre2 serverRAMPAGE

Identifiers

PMID31312380
PMCPMC6614651
OpenAlexW3022475319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.